Pradeep Tyagi1, Joseph Janicki2, Chan-Hong Moon3, Jonathan Kaufman2, Christopher Chermansky4. 1. Department of Urology, University of Pittsburgh, E313 Montefiore Hospital, 3459 Fifth Ave, Pittsburgh, PA, 15213, USA. tyagip@upmc.edu. 2. Lipella Pharmaceuticals Inc, Pittsburgh, PA, USA. 3. Department of Radiology, Magnetic Resonance Research Center, University of Pittsburgh, Pittsburgh, PA, USA. 4. Department of Urology, University of Pittsburgh, E313 Montefiore Hospital, 3459 Fifth Ave, Pittsburgh, PA, 15213, USA.
Abstract
PURPOSE: Instillation of novel contrast mixture (NCM) was recently shown to improve the contrast resolution of rat bladder wall with high contrast-to-noise ratio (CNR). Here, the clinical safety and the feasibility of NCM-enhanced MRI to achieve artifact-free visualization of human bladder wall suitable for quantitative measurement of the magnetic resonance (MR) longitudinal relaxation time (T1) was assessed. METHODS: Six female subjects [two controls and two with Hunner-type interstitial cystitis IC and two with non-Hunner-type IC] consented for MRI at 3 T before and after instillation of NCM [4 mM gadobutrol and 5 mM ferumoxytol in 50 mL of sterile water for injection]. Single breath-hold fast MR acquisition in large readout bandwidth for 5-mm-thick single slice with variable flip angle was applied to minimize the motion and chemical shift artifacts in measurements of bladder wall thickness (BWT), CNR and T1 from 20 pixels. RESULTS: NCM instillation in subjects did not evoke pain or discomfort. Fourfold increase in bladder wall CNR (*p < 0.02) and pixel size of 0.35 mm with minimal influence of artifacts allowed accurate determination of bladder wall thinning ~ 0.46 mm from 50 mL NCM (*p < 0.05). Pre-contrast bladder wall T1 of 1544 ± 34.2 ms was shortened to 860.09 ± 13.95 ms in Hunner-type IC (*p < 0.0001) relative to only 1257.42 ± 20.59 and 1258.16 ± 6.16 ms in non-Hunner-type IC and controls, respectively. CONCLUSION: Findings demonstrate the safety and feasibility of NCM-enhanced MRI to achieve artifact-free differential contrast and spatial resolution of human bladder wall, which is suitable for measuring BWT and pixel-wise measurement of T1 in post-contrast setting.
PURPOSE: Instillation of novel contrast mixture (NCM) was recently shown to improve the contrast resolution of rat bladder wall with high contrast-to-noise ratio (CNR). Here, the clinical safety and the feasibility of NCM-enhanced MRI to achieve artifact-free visualization of human bladder wall suitable for quantitative measurement of the magnetic resonance (MR) longitudinal relaxation time (T1) was assessed. METHODS: Six female subjects [two controls and two with Hunner-type interstitial cystitis IC and two with non-Hunner-type IC] consented for MRI at 3 T before and after instillation of NCM [4 mM gadobutrol and 5 mM ferumoxytol in 50 mL of sterile water for injection]. Single breath-hold fast MR acquisition in large readout bandwidth for 5-mm-thick single slice with variable flip angle was applied to minimize the motion and chemical shift artifacts in measurements of bladder wall thickness (BWT), CNR and T1 from 20 pixels. RESULTS: NCM instillation in subjects did not evoke pain or discomfort. Fourfold increase in bladder wall CNR (*p < 0.02) and pixel size of 0.35 mm with minimal influence of artifacts allowed accurate determination of bladder wall thinning ~ 0.46 mm from 50 mL NCM (*p < 0.05). Pre-contrast bladder wall T1 of 1544 ± 34.2 ms was shortened to 860.09 ± 13.95 ms in Hunner-type IC (*p < 0.0001) relative to only 1257.42 ± 20.59 and 1258.16 ± 6.16 ms in non-Hunner-type IC and controls, respectively. CONCLUSION: Findings demonstrate the safety and feasibility of NCM-enhanced MRI to achieve artifact-free differential contrast and spatial resolution of human bladder wall, which is suitable for measuring BWT and pixel-wise measurement of T1 in post-contrast setting.
Entities:
Keywords:
Ferumoxytol; Gadolinium; Human bladder; MRI; T1 mapping
Authors: K Takeda; T Kawaguchi; T Shiraishi; S Kobayashi; N Hayashi; M Yanagawa; H Tochigi; H Sakuma; J Kawamura; T Nakagawa Journal: Eur J Radiol Date: 1998-02 Impact factor: 3.528
Authors: Pradeep Tyagi; Joseph J Janicki; T Kevin Hitchens; Lesley M Foley; Mahendra Kashyap; Naoki Yoshimura; Jonathan Kaufman Journal: Am J Physiol Renal Physiol Date: 2017-03-29
Authors: C Tiderius; M Hori; A Williams; L Sharma; P V Prasad; M Finnell; C McKenzie; D Burstein Journal: Osteoarthritis Cartilage Date: 2006-06-16 Impact factor: 6.576
Authors: Bram F Coolen; Tessa Geelen; Leonie E M Paulis; Arno Nauerth; Klaas Nicolay; Gustav J Strijkers Journal: NMR Biomed Date: 2010-10-19 Impact factor: 4.044
Authors: Stephen J Walker; João Zambon; Karl-Erik Andersson; Carl D Langefeld; Catherine A Matthews; Gopal Badlani; Heather Bowman; Robert J Evans Journal: J Urol Date: 2017-02-12 Impact factor: 7.450
Authors: Rheal A Towner; Amy B Wisniewski; Dee H Wu; Samuel B Van Gordon; Nataliya Smith; Justin C North; Rayburt McElhaney; Christopher E Aston; S Abbas Shobeiri; Bradley P Kropp; Beverley Greenwood-Van Meerveld; Robert E Hurst Journal: J Urol Date: 2015-08-22 Impact factor: 7.450
Authors: Luke Xie; Anita T Layton; Nian Wang; Peder E Z Larson; Jeff L Zhang; Vivian S Lee; Chunlei Liu; G Allan Johnson Journal: Am J Physiol Renal Physiol Date: 2015-10-07
Authors: Pradeep Tyagi; Chan-Hong Moon; Joseph Janicki; Jonathan Kaufman; Michael Chancellor; Naoki Yoshimura; Christopher Chermansky Journal: F1000Res Date: 2018-11-09